TreeFrog Therapeutics
TreeFrog Therapeutics develops a pipeline of cell therapies in regenerative medicine using its proprietary C-Stem technology platform. The company produces 3D microtissues in large-scale bioreactors to treat diseases such as Parkinson’s and liver disease. Its business model includes both internal drug development and out-licensing its biomimetic encapsulation technology to pharmaceutical partners.
Visit websiteBordeaux, France
Biotechnology
Regenerative Medicine
Cell Therapy
Healthtech
Funding summary
- Total raised
- €71.0M
- Funding rounds
- 2
Investors in TreeFrog Therapeutics
Investors on record for TreeFrog Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like TreeFrog Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors